Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Hoskins; Jo Ann
Address:
Indianapolis, IN
No. of patents:
21
Patents:












Patent Number Title Of Patent Date Issued
H2085 Penicillin binding protein from Streptococcus pneumoniae October 7, 2003
The invention provides isolated nucleic acid compounds encoding a novel high molecular weight PBP of Streptococcus pneumoniae. Also provided are vectors and transformed heterologous host cells for expressing the PBP and a method for identifying compounds that bind and/or inhibit the enzy
H2070 Streptococcus pneumoniae gene sequence for DNA ligase July 1, 2003
The invention provides isolated nucleic acid compounds encoding a DNA ligase of Streptococcus pneumoniae. Also provided are vectors and transformed host cells for expressing the encoded protein, and a method for identifying compounds that bind and/or inhibit said protein.
H2023 Streptococcus pneumoniae sequence GrpE May 7, 2002
The invention provides isolated nucleic acid compounds encoding GrpE of Streptococcus pneumoniae. Also provided are vectors and transformed host cells for expressing the encoded protein, and a method for identifying compounds that bind and/or inhibit said protein.
H2021 Penicillin binding protein from Streptococcus pneumoniae May 7, 2002
The invention provides isolated nucleic acid compounds encoding a novel high molecular weight PBP of Streptococcus pneumoniae. Also provided are vectors and transformed heterologous host cells for expressing the PBP and a method for identifying compounds that bind and/or inhibit the enzy
6322998 Recombinant DNA compounds that encode ACV synthetase activity of Cephalosporium acremonium November 27, 2001
The present invention provides DNA compounds that encode ACV synthetase activity of Cephalosporium acremonium. The compounds can be used to construct recombinant DNA expression vectors for a wide variety of host cells, including E. coli, Penicillium, Cephalosporium, and Aspergillus.
6271000 Streptococcus pneumoniae gene sequence mraY August 7, 2001
The invention provides isolated nucleic acid compounds encoding enzyme mraY of Streptococcus pneumoniae. Also provided are vectors and transformed host cells for expressing the encoded enzyme, and a method for identifying compounds that inhibit said enzyme.
6268175 Streptococcus pneumoniae gene sequence GCP July 31, 2001
The invention provides isolated nucleic acid compounds encoding gcp of Streptococcus pneumoniae. Also provided are vectors and transformed host cells for expressing the encoded protein, and a method for identifying compounds that bind and/or inhibit said protein.
6171834 Muri protein from Streptococcus pneumoniae January 9, 2001
The invention provides isolated nucleic acid compounds encoding the stem peptide biosynthetic gene murI of Streptococcus pneumoniae. Also provided are vectors and transformed heterologous host cells for expressing the MurI enzyme product and a method for identifying compounds that inhibi
6162617 Streptococcus pneumoniae gene sequence dnaG December 19, 2000
The invention provides isolated nucleic acid compounds encoding dnaG of Streptococcus pneumoniae. Also provided are vectors and transformed host cells for expressing the encoded protein, and a method for identifying compounds that bind and/or inhibit said protein.
6143868 Monofunctional glycosyltransferase of Staphylococcus aureus November 7, 2000
The invention provides isolated nucleic acid compounds encoding a novel MTG of Staphylococcus aureus. Also provided are vectors and transformed heterologous host cells for expressing the MTG and a method for identifying compounds that bind and/or inhibit the enzymatic activity of the
5981281 Method for knockout mutagenesis in Streptococcus pneumoniae November 9, 1999
Provided herein is a method to produce knockout mutations at targeted sites in the genome of Streptococcus pneumoniae.
5948645 Biosynthetic gene muri from Streptococcus pneumoniae September 7, 1999
The invention provides isolated nucleic acid compounds encoding the stem peptide biosynthetic gene murI of Streptococcus pneumoniae. Also provided are vectors and transformed heterologous host cells for expressing the MurI enzyme product and a method for identifying compounds that inhibi
5922540 Monofunctional glycosyltransferase gene of Staphylococcus aureus July 13, 1999
The invention provides isolated nucleic acid compounds encoding a novel MTG of Staphylococcus aureus. Also provided are vectors and transformed heterologous host cells for expressing the MTG and a method for identifying compounds that bind and/or inhibit the enzymatic activity of the
5834270 Biosynthetic gene murD from streptococcus pneumoniae November 10, 1998
The invention provides isolated nucleic acid compounds encoding the murD stem peptide biosynthetic gene of Streptococcus pneumoniae. Also provided are vectors and transformed heterologous host cells for expressing the MurD enzyme product and a method for identifying compounds that inhibi
5821335 Biosynthetic gene murg from streptococcus pneumoniae October 13, 1998
The invention provides isolated nucleic acid compounds encoding the stem peptide biosynthetic gene murG of Streptococcus pneumoniae. Also provided are vectors and transformed heterologous host cells for expressing the MurG enzyme product and a method for identifying compounds that inhibi
5789202 DNA encoding a novel penicillin binding protein from streptococcus pneumoniae August 4, 1998
The invention provides isolated nucleic acid compounds encoding a novel high molecular weight PBP of Streptococcus pneumoniae. Also provided are vectors and transformed heterologous host cells for expressing the PBP and a method for identifying compounds that bind and/or inhibit the enzy
5710018 Mammalian influx peptide transporter January 20, 1998
The present invention provides isolated DNA compounds and recombinant DNA vectors that encode mammalian influx peptide transporter activity. The invention also provides host cells transformed with these vectors and a method for production of mammalian influx peptide transporter activity
5681694 Murd protein method and kit for identification of inhibitors October 28, 1997
The invention provides isolated nucleic acid compounds encoding the murD stem peptide biosynthetic gene of Streptococcus pneumoniae. Also provided are vectors and transformed heterologous host cells for expressing the MurD enzyme product and a method for identifying compounds that inhibi
5587307 FemA gene of staphylococcus epidermidis, femA protein, and vectors and microorganisms comprising December 24, 1996
The instant invention provides the femA gene of Staphylococcus epidermidis and all degenerate sequences thereof, the protein encoded by the femA gene (FemA), and vectors and microorganisms comprising genes encoding the FemA protein.
5328842 Compounds, vectors and methods for expressing human, cytosolic phospholipase A.sub.2 July 12, 1994
The invention includes recombinant DNA compounds, vectors and methods useful for expressing an exceptionally rare, human, cytosolic phospholipase A.sub.2 (cPLA.sub.2) enzyme. The invention also includes a method for screening compounds to identify inhibitors of cPLA.sub.2 which is be
4738921 Derivative of the tryptophan operon for expression of fused gene products April 19, 1988
The present invention comprises improved derivatives of the tryptophan operon useful for expressing fused gene products in E. coli and relate organism. Two of the improved derivatives disclosed are encoded on 0.43 and 0.55 kb EcoRI restriction fragments from plasmids pCZ20 and pLEBGH2










 
 
  Recently Added Patents
Driving apparatus having an optical sensor and a thermal sensor for thermal and aging compensation of backlight module and driving method of backlight module
Position and orientation measurement apparatus, position and orientation measurement method, and storage medium
Multi-protocol data transfers
Wavelength and power scalable waveguiding-based infrared laser system
Predicting performance of an integrated circuit
Adaptive flow for thermal cooling of devices
Method and apparatus for wireless communication in a mesh network with central control of communication relationships
  Randomly Featured Patents
N-{'4-substituted piperazine-1-sulfonylmethylalkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors
Method of and apparatus for recording color image
Fuel mixture regulator system
Cosmic radiation fault detection system
Coated catalysts and their preparation
Archery bow string release grip
Method for liquifying chloride-based heavy brine well completion fluids
Indexing multimedia communications
Sensors and sensing methods for detecting analytes based on changes in pKa of a sensing polymer
Method of mounting electronic components and apparatus therefor